Chemotherapy–birinapant combinations were most effective in reducing Caspase 8-deficient xenografts tumor growth rate by 2/3 after 8 weeks (Fig. 3C, *p < 0.05 compared to vehicle). Here, CASP8 is linked to neoplasm.